Jin Piao

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.257Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Papers

Driven by 21 papers — median percentile 41. Top paper: “Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial”.

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02838

N/A

0.722DataRank · unranked

122 citations

Katherine A. Janeway, David R. Patton, Cynthia L. Winter, Brent Coffey, P. Mickey Williams +16 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085

N/A

0.685DataRank · unranked

95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009

N/A

0.518DataRank · unranked

16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10007

N/A

0.464DataRank · unranked

21 citations

Alexander J. Chou, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009

N/A

0.464DataRank · unranked

21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

The Oncologist(2024)10.1093/oncolo/oyae119

N/A

0.363DataRank · unranked

7 citations

AeRang Kim, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10006

N/A

0.241DataRank · unranked

4 citations

Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo +14 more

Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10007

N/A

0.208DataRank · unranked

3 citations

Katherine A. Janeway, David R. Patton, Jennifer Lee, Brent Coffey, P. Mickey Williams +16 more

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10008

N/A

0.165DataRank · unranked

2 citations

Olive S. Eckstein, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors Committee

Pediatric Blood & Cancer(2025)10.1002/pbc.32164

N/A

0DataRank · unranked

1 citations

Jin Piao, Lindsay Younis, Reto M. Baertschiger, Kenneth S. Chen, Emily Christison‐Lagay +16 more

Children's Oncology Group's 2023 blueprint for research: Rare tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30574

N/A

0DataRank · unranked

4 citations

Murali Chintagumpala, Jin Piao, Kenneth S. Chen, Robyn D. Gartrell, Emily Christison‐Lagay +4 more

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.08.006

N/A

0DataRank · unranked

35 citations

John T. Lafin, Cinzia G. Scarpini, Michelle M. Nuño, Isabella Syring, Klaus‐Peter Dieckmann +9 more

Refining the serum miR-371a-3p test for viable germ cell tumor detection

Scientific Reports(2023)10.1038/s41598-023-37271-1

N/A

0DataRank · unranked

25 citations

Cinzia G. Scarpini, Armon Amini, Bendu Konneh, Jeffrey Howard, Thomas Gerald +18 more

Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective

EJC Paediatric Oncology(2023)10.1016/j.ejcped.2023.100024

N/A

0DataRank · unranked

11 citations

Murali Chintagumpala, Jin Piao, Kenneth S. Chen, Rachana Shah, Robyn D. Gartrell +15 more

A multi‐institutional feasibility study of intra‐arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1)

Pediatric Blood & Cancer(2023)10.1002/pbc.30718

N/A

0DataRank · unranked

8 citations

Jin Piao, Dan S. Gombos, Patricia Chévez‐Barrios, Lindsay Brock, Ira J. Dunkel +7 more

A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)

Pediatric Blood & Cancer(2020)10.1002/pbc.28502

N/A

0DataRank · unranked

16 citations

Judith G. Villablanca, Mark Krailo, Jin Piao, Li Huang, A. Linn Murphree +6 more

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range

Research Square(2023)10.21203/rs.3.rs-2644890/v1

N/A

0DataRank · unranked

3 citations

Cinzia G. Scarpini, Armon Amini, Bendu Konneh, Jeffrey Howard, Thomas Gerald +18 more

AGCT1531: Evaluating the utility of circulating microRNA in the management of children, adolescents, and adults with malignant germ cell tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5104

N/A

0DataRank · unranked

3 citations

Aditya Bagrodia, James F. Amatruda, Michelle M. Nuño, Matthew J. Murray, Nicholas Coleman +8 more

On the use of external controls in clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae046

N/A

0DataRank · unranked

5 citations

Stephanie L. Pugh, Lingyun Ji, Jin Piao, James J. Dignam, Jon A. Steingrimsson +1 more

Conformal predictive intervals in survival analysis: a resampling approach

Biometrics(2025)10.1093/biomtc/ujaf063

N/A

0DataRank · unranked

3 citations

Jin Piao, Jing Ning, Yu Shen, Jing Qin

Jin Piao

Indexed papers

Top data-sharing exemplar

Papers